Bibliography
- COLEMAN R, KENNEDY I, HUMPHREY P et al.: Prostanoids and their receptors. In: Comprehensive Medicinal Chemistry Membranes and receptors, Volume 3. Emmett JC (Ed), Pergamon, Oxford (1990):643–714.
- ••Prostanoid receptor classification.
- BREYER R, BAGDASSARIAN C, MYERS S et al.: Prostanoid receptors: subtypes and signaling. Ann. Rev Pharmacol Toxicol (2001) 41:661–690.
- ••Prostanoid receptor description.
- MURAT T, USHEKUBI F, MATSUOKA T et al.: Altered pain perception and inflammatory response in mice lacking prostacyclin receptor. Nature (1997) 388:678–682.
- HOEPER MM, SCHWARZE M, EHLERDING S et al.: Long-term treatment of primary pulmonary hypertension with aerosolized iloprost, a prostacyclin analogue. N Engl. Med. (2000) 342:1866–1870.
- TUDER RM, COOL CD, GERACI MW et al.: Prostacyclin synthase expression is decreased in lungs from patients with severe pulmonary hypertension. Am. I Respic Grit. Care Med. (1999) 159:1925–1932.
- LEWIS RA, SOTER NA, DIAMOND PTet al: Prostaglandin D2 generation after activation of rat and human mast cells with anti-IgE. Immunol (1982) 129: 1627-1631.
- URADE Y, HAYAISHI O: Prostaglandin D2 and sleep regulation. Biochim. Biophys. Acta. (1999) 1436:606–615.
- SRI KANTHA S, MATSUMURA H, KUBO E et al: Effects of prostaglandin D2, lipoxins and leukotrienes on sleep and brain temperature of rats. Prostagandins Leukot. Essent. Fatty Acids. (1994) 51:87–93.
- GILLES H, LEFF P, BOLOF0 ML et al: The classification of prostaglandin DP-receptors in platelets and vasculature using BW A868C, a novel, selective and potent competitive antagonist. Drj Pharmacol (1989) 96:291–300.
- SUGIMOTO Y, YAMASAKI A, SEGI E et al.: Failure of parturition in mice lacking the prostaglandin F receptor. Science (1997) 277:681–683.
- LYDFORD S, McKECHNIE K, DOUGALL I: Pharmacological studies on prostanoid receptors in the rabbit isolated saphenous vein: a comparison with the rabbit isolated ear artery. Br. Pharmacol (1996) 117:13–20.
- COLEMAN RA, GRIX SP, HEAD SA et al.: A novel inhibitory prostanoid receptor in piglet saphenous vein. Prostaglandins (1994) 47:151–168.
- LAWRENCE RA, JONES RL: Investigationof the prostaglandin E (EP-) receptor subtype mediating relaxation of the rabbit jugular vein. Br. Pharmacol (1992) 105:817–824.
- DANIELS E, HINMAN J, LEACH B et al.: Identification of prostaglandin E2 as the principal vasodepressor lipid of rabbit renal medulla. Nature (1967) 215:1298–1299.
- COLEMAN RA, SMITH WL, NARUMIYA S: International Union of Pharmacology classification of prostanoid receptors: properties, distribution, and structure of the receptors and their subtypes. Pharmacol Rev (1994) 46:205–229.
- ••Pharmacology of prostanoid receptors.
- KIRIYAMA M, USHIKUBI F, KOBAYASHI T et al.: Ligand binding specificities of the eight types and subtypes of mouse prostanoid receptors expressed in Chinese hamster ovary cells. Br.Pharmacol (1997) 122:217–224.
- BOIE Y, STOCCO R, SAWYER N et al.:Molecular cloning and characterization of the four rat prostaglandin E2 prostanoid receptor subtypes. Ear: Pharmacol (1997) 340:227–241.
- GARDINER PJ: Characterization of prostanoid relaxant/inhibitory receptors (psi) using a highly selective agonist, TR4979. Br: J. Pharmacol (1986) 87:45–56.
- SEGI E, SUGIMOTO Y, YAMASAKI A et al.: Patent ductus arteriosus and neonatal death in prostaglandin receptor EP4-deficient mice. Biochem. Biophys. Res. Commun. (1998) 246:7–12.
- NGUYEN M, CAMENISCH T, SNOUWAERT J et al: The prostaglandin receptor EP4 triggers remodelling of the cardiovascular system at birth. Nature (1997) 390:78–81.
- DE LEVAL X, DELARGE J, SOMERS F et al.: Recent advances in inducible cyclooxygenase (COX-2) inhibition. Can: Med. Chem. (2000) 10:1041–1062.
- DE LEVAL X, JULEMONT F, DELARGE J et al.: Recent advances in the file of COX-2 inhibition. Expert Opin. Ther: Patents (2002) 12(7):969–989.
- DOGNE JM, DE LEVAL X, DELARGE J et al.: Recent developments of thromboxane modulators. Expert Opin. Ther: Patents (2001) 11(11)1663–1675.
- ••Review of thromboxane modulators.